|
Lenbelintide Clinical Trials
3 actively recruiting trials across 3 locations
Also known as: AZD6234
Pipeline
Phase 3: 3
Top Sponsors
- AstraZeneca3
Indications
- Obesity or Overweight3
- Diabetes3
- With/Without Diabetes Mellitus, Type 21
- Weight-Related Comorbidity1
- Diabetes Mellitus, Type 21
Dothan, Alabama1 trial
Fairhope, Alabama1 trial
Escondido, California1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.